Unicycive Therapeutics Statistics

Total Valuation

UNCY has a market cap or net worth of $63.73 million. The enterprise value is $32.19 million.

Market Cap	63.73M
Enterprise Value	32.19M

Important Dates

The next estimated earnings date is Monday, May 12, 2025, after market close.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

UNCY has 103.80 million shares outstanding. The number of shares has increased by 151.45% in one year.

Current Share Class	103.80M
Shares Outstanding	103.80M
Shares Change (YoY)	+151.45%
Shares Change (QoQ)	-5.43%
Owned by Insiders (%)	6.12%
Owned by Institutions (%)	21.26%
Float	54.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.16
P/TBV Ratio	2.29
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.61, with a Debt / Equity ratio of 0.03.

Current Ratio	3.61
Quick Ratio	3.09
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-416.70

Financial Efficiency

Return on equity (ROE) is -147.05% and return on invested capital (ROIC) is -110.63%.

Return on Equity (ROE)	-147.05%
Return on Assets (ROA)	-62.85%
Return on Invested Capital (ROIC)	-110.63%
Return on Capital Employed (ROCE)	-103.75%
Revenue Per Employee	n/a
Profits Per Employee	-$1.72M
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -57.95% in the last 52 weeks. The beta is 2.25, so UNCY's price volatility has been higher than the market average.

Beta (5Y)	2.25
52-Week Price Change	-57.95%
50-Day Moving Average	0.59
200-Day Moving Average	0.52
Relative Strength Index (RSI)	51.63
Average Volume (20 Days)	789,104

Short Selling Information

The latest short interest is 1.52 million, so 1.47% of the outstanding shares have been sold short.

Short Interest	1.52M
Short Previous Month	1.40M
Short % of Shares Out	1.47%
Short % of Float	2.79%
Short Ratio (days to cover)	1.93

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-29.17M
Pretax Income	-36.93M
Net Income	-24.10M
EBITDA	-29.15M
EBIT	-29.17M
Earnings Per Share (EPS)	-$0.49

Full Income Statement

Balance Sheet

The company has $32.35 million in cash and $807,000 in debt, giving a net cash position of $31.54 million or $0.30 per share.

Cash & Cash Equivalents	32.35M
Total Debt	807,000
Net Cash	31.54M
Net Cash Per Share	$0.30
Equity (Book Value)	27.85M
Book Value Per Share	0.28
Working Capital	27.28M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$26.47 million and capital expenditures -$50,000, giving a free cash flow of -$26.52 million.

Operating Cash Flow	-26.47M
Capital Expenditures	-50,000
Free Cash Flow	-26.52M
FCF Per Share	-$0.26

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

UNCY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-151.45%
Shareholder Yield	n/a
Earnings Yield	-37.81%
FCF Yield	-41.61%

Analyst Forecast

The average price target for UNCY is $5.33, which is 768.08% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.33
Price Target Difference	768.08%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	191.27%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

UNCY has an Altman Z-Score of -2.78 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.78
Piotroski F-Score	1